These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8475477)

  • 1. Relationship of plasminogen activator inhibitor-1 with plasma insulin, glucose, triglyceride and cholesterol in Chinese patients with diabetes.
    Ho CH; Jap TS
    Thromb Res; 1993 Feb; 69(3):271-7. PubMed ID: 8475477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of high fat diet on the fibrinolytic activity.
    Ho CH; Chwang LC; Hwang BH
    Thromb Res; 1995 Feb; 77(3):201-8. PubMed ID: 7740512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
    Aso Y; Wakabayashi S; Yamamoto R; Matsutomo R; Takebayashi K; Inukai T
    Diabetes Care; 2005 Sep; 28(9):2211-6. PubMed ID: 16123492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.
    Cigolini M; Targher G; Seidell JC; Schiavon R; Manara F; Zenti MG; Mattioli C; De Sandre G
    Atherosclerosis; 1994 Apr; 106(2):139-47. PubMed ID: 8060375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.
    Eliasson M; Asplund K; Evrin PE; Lindahl B; Lundblad D
    Metabolism; 1994 Dec; 43(12):1579-86. PubMed ID: 7990715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana.
    Nkansah C; Addai-Mensah O; Mensah K; Owusu M; Ephraim RKD; Adu P; Osei-Boakye F; Appiah SK; Serwaa D; Derigubah CA; Debrah AY
    PLoS One; 2021; 16(4):e0250090. PubMed ID: 33857223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of vegetarianism on fibrinolytic activity.
    Ho CH; Chwang LC
    Proc Natl Sci Counc Repub China B; 1993 Jan; 17(1):35-9. PubMed ID: 8234542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Shahar E; Folsom AR; Salomaa VV; Stinson VL; McGovern PG; Shimakawa T; Chambless LE; Wu KK
    Circulation; 1996 Jun; 93(11):1970-5. PubMed ID: 8640970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.
    De Mitrio V; De Pergola G; Vettor R; Marino R; Sciaraffia M; Pagano C; Scaraggi FA; Di Lorenzo L; Giorgino R
    Metabolism; 1999 Aug; 48(8):960-4. PubMed ID: 10459558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
    Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy.
    Kissebah AH; Kohner EM; Lewis B; Siddiq YK; Lowy C; Fraser TR
    Lancet; 1975 May; 1(7916):1104-8. PubMed ID: 49469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.